Press releases

Latest News

Symbol image
New approaches to treatment of ALS at the DZNE
A drug from immunotherapy could slow down the progression of the severe neurodegenerative disease.
Speech as a new diagnostic tool in ALS and FTD
The speech of patients with neurodegenerative diseases gradually changes. Thanks to the help of artificial intelligence, even the slightest changes can become the basis for a diagnosis.
Image shows blood samples
Biomarkers from the blood for Alzheimer's diagnosis
About 3.000 blood samples will be analyzed for a research network led by the DZNE.
NEUROCOV
New EU Research Project Investigates Neurological and Neuropsychiatric Complications Following COVID-19 Infections
Drug Testing with Artificial Brain Vessels
Screening method simulates filter effect of the “blood-brain barrier”.
[Translate to Englisch:]
Research for a healthy brain: 10,000 Bonn residents get involved in the "Rhineland Study
Bonn Mayor Katja Dörner visits study center.
Puzzling Exhaustion: Consortium Explores Causes of ME/CFS
DZNE participates in a research alliance that aims to investigate the causes of “Myalgic Encephalomyelitis/Chronic Fatigue Syndrome” (ME/CFS).
The Brain Already Benefits from Moderate Physical Activity
Brain regions with high oxygen demand show the largest effects.
Virtual reality scenario.
Start-up “neomento”: Virtual Therapy Against Real Anxieties
Technology from dementia research in the service of psychotherapy.
Computing center.
International Conference on AI and Neuroscience in September
“Nature”-Conference “AI, Neuroscience and Hardware” focuses on exchange between biology and IT technology.

Welcome to our website, here you can inform yourself basically cookie-free.

We would be pleased if you would allow a cookie to be set for analysis purposes in order to optimise our provided information. All data are pseudonymous and are only used by the DZNE. We deliberately avoid third-party cookies. You can deselect this setting at any time here.

Your browser allows the setting of cookies: